Carl Erik Heiberg

Counsel

Disclaimer

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

Carl Erik Heiberg is an established corporate transactional lawyer specializing in mergers and acquisitions, foreign direct investments into China, fund formation, private equity investments, and international anti-corruption investigations and compliance. Prior to joining O’Melveny, Carl clerked for a New York State Supreme Court Justice for two years. Additionally, he worked in the Shanghai office of another law firm for approximately four years before attending law school.

Languages

  • Mandarin Chinese

Admissions

Bar Admissions

  • New York

Education

  • University of Minnesota, J.D.: cum laude
  • The Johns Hopkins University - Nanjing University Center for Chinese and American Studies, Certificate, International Relations
  • Swarthmore College, B.A., Economics and Chinese Studies

Professional Activities

Law Clerk

  • Honorable Jane S. Solomon, New York State Supreme Court

Author

  • Practice Note, “Due diligence process in China acquisitions,” Practical Law China (2018)
  • Practice Note, “Due diligence process in China acquisitions,” Practical Law (2014)
  • Note, “American Films in China: An Analysis of China's Intellectual Property Record and Reconsideration of Cultural Trade Exceptions Amidst Rampant Piracy,” 15 Minn.J.Int'l L.219 (2006) 

Co-Author

  • “China Tightens Restrictions on Foreign Representative Offices,” the China Business Review (September-October 2010) 
  • “Ministry of Culture Issues Comprehensive Regulation on Online Games,” Asia IP (September 2009) 

Articles Editor

  • Minnesota Journal of International Law

Teacher

  • Brooklyn Technical High School, Brooklyn, New York (1996-98) 
  • Pharmaron in multiple outbound acquisitions and investments, including its US$137.5 million acquisition of US-based Absorption Systems and its US$118.7 million acquisition of a state-of-art biomanufacturing site in the United Kingdom from AbbVie
  • A contract research organization incorporated in Cayman Islands in its US$80 million sale to a consortium led by a Boston-based private equity fund
  • A Chinese listed company in its multiple acquisitions of private U.S. medical products companies
  • A U.S. information technology, product and services company in its joint venture with a Chinese electronics company to bring online meeting and videoconferencing applications to the Chinese market
  • An American media and entertainment company in its joint venture and related licensing matters with a Chinese entertainment, media, and internet company to distribute foreign motion pictures in China via the internet
  • The founders of a leading Chinese wine, spirit, and beverage importation and distribution company in the divestiture of their business to an Australian liquor company
  • A U.S.-based pharmaceutical contract services company on its offshore joint venture with a China-based pharmaceutical contract research company, the joint venture’s establishment of a wholly-owned China subsidiary, and the client’s subsequent buyout of its joint venture partner
  • One of the world’s largest fragrance corporations in acquiring a leading Chinese skin care company
VIEW MORE